Sabai Group LLC (“Sabai”), a provider of custom solutions for biosafety and human research protections, today announced the acquisition of Alpha Independent Review Board, LLC (“Alpha IRB”). Headquartered in San Clemente, CA, Alpha IRB provides Institutional Review Board (“IRB”) services for biopharma sponsors, CROs, and site networks conducting clinical trials. Sabai’s acquisition of Alpha IRB marks a significant milestone in the growth and expansion of both companies. Alpha IRB’s bench of talented IRB professionals and board members has deep experience in growing therapeutic areas that complements not only Sabai’s existing IRB capabilities, but also its Institutional Biosafety Committee (“IBC”) and cell-gene therapy focused service offerings.
Read the full article: Sabai Completes Acquisition of Alpha IRB //
Source: https://www.prnewswire.com/news-releases/sabai-completes-acquisition-of-alpha-irb-302031585.html